April 2, 2013

DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals' Zephrex-D, a pseudoephedrine product with a unique point of differentiation.

August 31, 2015

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

August 28, 2015

Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.

August 28, 2015

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

August 27, 2015

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

August 25, 2015

Glucose monitoring device company Dexcom announced Tuesday that the Food and Drug Administration had approved its G5 Mobile Continuous Glucose Monitoring System.

August 20, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 20, 2015

Cosmederm Bioscience’s Tri-Calm OTC itch relief solution is quickly climbing the anti-itch treatment product chart with growth of 148.2% to a dollar base of $4.9 million for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI.

August 19, 2015

The Food and Drug Administration handed down its anticipated approval of Sprout Pharmaceuticals’ Addyi, a treatment for women with generalized hypoactive sexual desire disorder. 

August 18, 2015

Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.

August 12, 2015

The online guide includes information about the benefits and risks of vaccination, the types of vaccines children routinely receive as well as a section with questions that parents are asking about vaccination.

August 10, 2015

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.

August 10, 2015

In order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and support. 

August 10, 2015

The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.

August 6, 2015

Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax. 

August 5, 2015

Manufacturers Atrium, Aspen Group, Nutri-Pak of Wisconsin will have to get a special clearance from FDA before producing supplements again. 

August 5, 2015

The FDA and industry have been working together to make liquid formulations of acetaminophen safer for children. 

August 5, 2015
Par Pharmaceutical announced Wednesday that the Food and Drug Administration had granted final approval of the company’s generic version of Sodium Edecrin (ethacrynate sodium) for injection.
August 4, 2015
The Food and Drug Administration has approved Aprecia Pharmaceuticals’ Spritam (levetiracetam), an epilepsy treatment that is the first FDA-approved drug that uses 3D printing technology. 
July 31, 2015

Bayer HealthCare Pharmaceuticals on Friday announced that the Food and Drug Administration approved the company’s Finacea (azelaic acid) Foam, 15% for the topical treatment rosacea.

July 28, 2015

The Council for Responsible Nutrition will host a conversation with key regulators of the dietary supplement industry at annual meeting. 

July 24, 2015

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.

July 24, 2015

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

July 23, 2015

A new coalition has formed to ensure safe access to over-the-counter pain relief remedies. The Protecting Access to Pain Relief Coalition officially launched on June 22 to help ensure that American consumers continue to have access to, and choice of, safe and effective pain relief, including acetaminophen.